| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |